40 min listen
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap
ratings:
Length:
37 minutes
Released:
Nov 18, 2022
Format:
Podcast episode
Description
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:COVID-19 vaccines, including omicron BA.1 bivalent boosterRisk factors for breakthrough COVID-19 infectionsCOVID-19 diagnostics, including digital droplet PCRCOVID-19 therapeutics, including:Nirmatrelvir plus ritonavirTixagevimab plus cilgavimabBaricitinibTocilizumabInhaled interferon β-1aCOVID-19 therapeutics and outcomes in patients with immunocompromiseLong COVIDPresenters:Princy N. Kumar, MD, FIDSA, MACPProfessor of Medicine and MicrobiologyChief, Division of Infectious Diseases and Travel MedicineSenior Associate Dean of StudentsGeorgetown University School of MedicineWashington, DCPaul E. Sax, MDClinical DirectorHIV Program and Division of Infectious DiseasesBrigham and Women’s HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsFollow along with the downloadable slideset at:http://bit.ly/3gkJI67Link to full program:http://bit.ly/3TSVthM
Released:
Nov 18, 2022
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 1: In Part 1 of this ongoing 12-part COVID-19 series, listen to a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data on evidence-based antiviral therapy for severe disease followed by answers to critical clinician questions on COVID-19 transmission, diagnosis, and management from frontline provider Vikramjit Mukherjee, MD. by CCO Infectious Disease Podcast